Featured

TIF publishes new material on the COVID-10 Pandemic
TIF News (AR)

TIF publishes new material on the COVID-10 Pandemic

TIF continues the efforts to address the questions and concerns of its global patients’ and healthcare professionals’ community about the COVID-19 Pandemic and, in doing so, it has issued 2…
A consortium of life sciences companies jointly commit expertise & assets to fight COVID-19 alongside the Bill & Melinda Gates Foundation
أخبار

A consortium of life sciences companies jointly commit expertise & assets to fight COVID-19 alongside the Bill & Melinda Gates Foundation

An unprecedented collaboration across government, academia, private sector, and philanthropy is taking place as a response to the coronavirus global crisis. Today, a consortium of life sciences companies announced an…
FDA and EMA Collaborate to Facilitate COVID-19 Vaccine Development
أخبار

FDA and EMA Collaborate to Facilitate COVID-19 Vaccine Development

  Global regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine development that was convened under the umbrella of the International Coalition of Medicines…
The changing epidemiology of the ageing thalassaemia populations: A new position statement by TIF
TIF News (AR)

The changing epidemiology of the ageing thalassaemia populations: A new position statement by TIF

Therapeutic advances in β-thalassaemia have gradually led to a significant improvement in prognosis over the past few decades. As a result, patients living in areas where disease specific programmes offer…
Novartis To Donate Up To 130 Million Doses Of Hydroxychloroquine To Treat Covid-19
أخبار

Novartis To Donate Up To 130 Million Doses Of Hydroxychloroquine To Treat Covid-19

  On Friday, 20 March, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response. Hydroxychloroquine and a related…
TIF’s enriched Leaflet ”The COVID-19 Pandemic & Haemoglobin Disorders” is available today!
TIF News (AR)

TIF’s enriched Leaflet ”The COVID-19 Pandemic & Haemoglobin Disorders” is available today!

During these difficult and challenging times the coronavirus (COVID-19) pandemic is creating at a global level, individuals with underlying medical conditions, such as blood disorders, heart disease, chronic liver disease,…
A Useful Health & Nutrition Short Guide for the COVID-19 Pandemic by TIF
TIF News (AR)

A Useful Health & Nutrition Short Guide for the COVID-19 Pandemic by TIF

The coronavirus presents many uncertainties, and none of us can completely eliminate the risk of getting infected with COVID-19. Nevertheless, one thing we can do is eat as healthy as…
AABB’s Develops Toolkit with Information Regarding Blood Donation & the COVID-19 Outbreak
Clinical News

AABB’s Develops Toolkit with Information Regarding Blood Donation & the COVID-19 Outbreak

  As the new coronavirus continues to spread affecting an increasing number of countries around the globe and in response to FDA’s Important Information for Blood Establishments Regarding the Novel Coronavirus…
A DECENT LIFE WITH THALASSAEMIA by Dimitri Azzopardi
Patients’ stories

A DECENT LIFE WITH THALASSAEMIA by Dimitri Azzopardi

  “My family is from Greece originally but I was born and grew up in Wales, a country which even today has very few thalassaemia patients. When I was born…
FT-4202 Granted FDA Fast Track, Rare Pediatric Disease Designations for SCD
Clinical News

FT-4202 Granted FDA Fast Track, Rare Pediatric Disease Designations for SCD

FT-4202, a potential disease-modifying oral treatment for sickle cell disease being developed by Forma Therapeutics, has been given fast track and rare pediatric disease designations by the U.S. Food and Drug Administration (FDA). A fast track status…
زر الذهاب إلى الأعلى
إغلاق
إغلاق